Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce Singh

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
The Australian and New Zealand Journal of Psychiatry|December 22, 2023
Seven decades of antipsychotic drugs: Why is the life of Australians with schizophrenia still so suboptimal?David Castle, David Copolov, Bruce Singh, et al.
The Australian and New Zealand Journal of Psychiatry|May 2, 2002
Psychiatry and the need for mental health care in Australia: findings from the National Survey of Mental Health and WellbeingGraham Meadows, Bruce Singh, Philip Burgess, et al.
Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists|February 18, 2005
Partnerships between academic psychiatry and the pharmaceutical industry: the Lilly MAP InitiativeBruce Singh, David Copolov, David Grainger, et al.
Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists|September 22, 2005
Development of clinical guidelines for the pharmacological management of behavioural disturbance and aggression in people with psychosisDavid Castle, Jeffrey Daniel, Jonathan Knott, et al.
Psychiatric Services (Washington, D.C.)|April 11, 2006
Multiple-family group treatment for English- and Vietnamese-speaking families living with schizophreniaGail M Bradley, Grace M Couchman, Amaryll Perlesz, et al.
Schizophrenia Research|February 5, 2008
World Psychiatric Association Pharmacopsychiatry Section statement on comparative effectiveness of antipsychotics in the treatment of schizophreniaRajiv Tandon, R H Belmaker, Wagner F Gattaz, et al.
The American Journal of Psychiatry|September 30, 2003
Impairment of olfactory identification ability in individuals at ultra-high risk for psychosis who later develop schizophreniaWarrick J Brewer, Stephen J Wood, Patrick D McGorry, et al.
The Lancet. Psychiatry|February 22, 2017
Neuroscience in gambling policy and treatment: an interdisciplinary perspectiveMurat Yücel, Adrian Carter, Amy R Allen, et al.
The Australian and New Zealand Journal of Psychiatry|May 31, 2023
The Australian evidence-based clinical practice guideline for attention deficit hyperactivity disorderTamara May, Edwina Birch, Karina Chaves, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
The Australian and New Zealand Journal of Psychiatry|December 22, 2023
Seven decades of antipsychotic drugs: Why is the life of Australians with schizophrenia still so suboptimal?David Castle, David Copolov, Bruce Singh, et al.
The Australian and New Zealand Journal of Psychiatry|May 2, 2002
Psychiatry and the need for mental health care in Australia: findings from the National Survey of Mental Health and WellbeingGraham Meadows, Bruce Singh, Philip Burgess, et al.
Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists|February 18, 2005
Partnerships between academic psychiatry and the pharmaceutical industry: the Lilly MAP InitiativeBruce Singh, David Copolov, David Grainger, et al.
Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists|September 22, 2005
Development of clinical guidelines for the pharmacological management of behavioural disturbance and aggression in people with psychosisDavid Castle, Jeffrey Daniel, Jonathan Knott, et al.
Psychiatric Services (Washington, D.C.)|April 11, 2006
Multiple-family group treatment for English- and Vietnamese-speaking families living with schizophreniaGail M Bradley, Grace M Couchman, Amaryll Perlesz, et al.
Schizophrenia Research|February 5, 2008
World Psychiatric Association Pharmacopsychiatry Section statement on comparative effectiveness of antipsychotics in the treatment of schizophreniaRajiv Tandon, R H Belmaker, Wagner F Gattaz, et al.
The American Journal of Psychiatry|September 30, 2003
Impairment of olfactory identification ability in individuals at ultra-high risk for psychosis who later develop schizophreniaWarrick J Brewer, Stephen J Wood, Patrick D McGorry, et al.
The Lancet. Psychiatry|February 22, 2017
Neuroscience in gambling policy and treatment: an interdisciplinary perspectiveMurat Yücel, Adrian Carter, Amy R Allen, et al.
The Australian and New Zealand Journal of Psychiatry|May 31, 2023
The Australian evidence-based clinical practice guideline for attention deficit hyperactivity disorderTamara May, Edwina Birch, Karina Chaves, et al.
Pageof 2